-+ 0.00%
-+ 0.00%
-+ 0.00%

AbbVie announced that the CERVINO phase III clinical trial obtained positive primary endpoint data.

智通財經·09/03/2026 13:17:10
語音播報
AbbVie announced that the CERVINO phase III clinical trial obtained positive primary endpoint data.